Immune Checkpoint Inhibitors Mediated Lymphocytic and Giant Cell Myocarditis: Uncovering Etiological Mechanisms

Immune Checkpoint Inhibitors Mediated Lymphocytic and Giant Cell Myocarditis: Uncovering Etiological Mechanisms

The advent of immune checkpoint inhibitors (ICIs) has revolutionized the field of oncology, but these are associated with immune related adverse events. One such adverse event, is myocarditis, which has limited the continued immunosuppressive treatment options in patients afflicted by the disease. P...

Full description

Bibliographic Details
Main Authors: Rishi Rikhi, Jaret Karnuta, Muzna Hussain, Patrick Collier, Pauline Funchain, Wai Hong Wilson Tang, Timothy A. Chan, Rohit Moudgil
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
cardio-oncology
immune checkpoint inhibitor
immune-related adverse event
cardiovascular adverse event
myocarditis
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.721333/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.721333/full

Similar Items